Janus Henderson Group’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Hold |
22,456
| – | – | ﹤0.01% | 1371 |
|
|
2025
Q1 | $1.42M | Sell |
22,456
-37,980
| -63% | -$2.4M | ﹤0.01% | 1446 |
|
|
2024
Q4 | $4.72M | Buy |
60,436
+13,920
| +30% | +$1.09M | ﹤0.01% | 930 |
|
|
2024
Q3 | $3.74M | Buy |
46,516
+7,417
| +19% | +$596K | ﹤0.01% | 1002 |
|
|
2024
Q2 | $3.24M | Buy |
39,099
+9,369
| +32% | +$775K | ﹤0.01% | 1032 |
|
|
2024
Q1 | $2.54M | Buy |
29,730
+6,287
| +27% | +$536K | ﹤0.01% | 1181 |
|
|
2023
Q4 | $2.01M | Buy |
23,443
+688
| +3% | +$58.9K | ﹤0.01% | 1250 |
|
|
2023
Q3 | $2.04M | Buy |
22,755
+4
| +0% | +$358 | ﹤0.01% | 1178 |
|
|
2023
Q2 | $1.94M | Sell |
22,751
-29
| -0.1% | -$2.47K | ﹤0.01% | 1262 |
|
|
2023
Q1 | $1.88M | Buy |
22,780
+12,287
| +117% | +$1.02M | ﹤0.01% | 1302 |
|
|
2022
Q4 | $825K | Buy |
10,493
+1,569
| +18% | +$123K | ﹤0.01% | 1462 |
|
|
2022
Q3 | $661K | Sell |
8,924
-1,378
| -13% | -$102K | ﹤0.01% | 1839 |
|
|
2022
Q2 | $671K | Sell |
10,302
-18
| -0.2% | -$1.17K | ﹤0.01% | 1576 |
|
|
2022
Q1 | $652K | Sell |
10,320
-433,545
| -98% | -$27.4M | ﹤0.01% | 1736 |
|
|
2021
Q4 | $23.5M | Sell |
443,865
-760,819
| -63% | -$40.4M | 0.01% | 748 |
|
|
2021
Q3 | $85M | Buy |
1,204,684
+512,612
| +74% | +$36.2M | 0.04% | 394 |
|
|
2021
Q2 | $46.1M | Buy |
+692,072
| New | +$46.1M | 0.02% | 584 |
|